Trial · NCT03809429
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Procedural pain | Injury, poisoning and procedural complications | FE 999049 + GnRH Agonist (GONAPEPTYL) | 20 | 202 | 20 |
| other | Procedural pain | Injury, poisoning and procedural complications | FE 999049 + GnRH Antagonist (CETROTIDE) | 12 | 204 | 12 |
| other | Headache | Nervous system disorders | FE 999049 + GnRH Agonist (GONAPEPTYL) | 27 | 202 | 31 |
| other | Headache | Nervous system disorders | FE 999049 + GnRH Antagonist (CETROTIDE) | 29 | 204 | 30 |
| other | Biochemical pregnancy | Pregnancy, puerperium and perinatal conditions | FE 999049 + GnRH Agonist (GONAPEPTYL) | 10 | 202 | 10 |
| other | Biochemical pregnancy | Pregnancy, puerperium and perinatal conditions | FE 999049 + GnRH Antagonist (CETROTIDE) | 11 | 204 | 11 |
| other | Pelvic pain | Reproductive system and breast disorders | FE 999049 + GnRH Agonist (GONAPEPTYL) | 14 | 202 | 15 |
| other | Pelvic pain | Reproductive system and breast disorders | FE 999049 + GnRH Antagonist (CETROTIDE) | 11 | 204 | 12 |
| other | Ovarian hyperstimulation syndrome | Reproductive system and breast disorders | FE 999049 + GnRH Agonist (GONAPEPTYL) | 12 | 202 | 12 |
| other | Ovarian hyperstimulation syndrome | Reproductive system and breast disorders | FE 999049 + GnRH Antagonist (CETROTIDE) | 11 | 204 | 11 |
| serious | Appendicitis | Infections and infestations | FE 999049 + GnRH Agonist (GONAPEPTYL) | 1 | 202 | 1 |
| serious | Appendicitis | Infections and infestations | FE 999049 + GnRH Antagonist (CETROTIDE) | 0 | 204 | 0 |
| serious | Bacterial abdominal infection | Infections and infestations | FE 999049 + GnRH Agonist (GONAPEPTYL) | 1 | 202 | 1 |
| serious | Bacterial abdominal infection | Infections and infestations | FE 999049 + GnRH Antagonist (CETROTIDE) | 0 | 204 | 0 |
| serious | Hyperemesis gravidarum | Pregnancy, puerperium and perinatal conditions | FE 999049 + GnRH Agonist (GONAPEPTYL) | 0 | 202 | 0 |
| serious | Hyperemesis gravidarum | Pregnancy, puerperium and perinatal conditions | FE 999049 + GnRH Antagonist (CETROTIDE) | 1 | 204 | 1 |
| serious | Ovarian hyperstimulation syndrome | Reproductive system and breast disorders | FE 999049 + GnRH Agonist (GONAPEPTYL) | 2 | 202 | 2 |
| serious | Ovarian hyperstimulation syndrome | Reproductive system and breast disorders | FE 999049 + GnRH Antagonist (CETROTIDE) | 4 | 204 | 4 |
| serious | Adnexal torsion | Reproductive system and breast disorders | FE 999049 + GnRH Agonist (GONAPEPTYL) | 0 | 202 | 0 |
| serious | Adnexal torsion | Reproductive system and breast disorders | FE 999049 + GnRH Antagonist (CETROTIDE) | 1 | 204 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03809429/events